Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNT1 | O60563 | 10/20 | 0.44 |
| ▸ | CDK9 | P50750 | 10/20 | 0.44 |
| ▸ | BRD4 | O60885 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CCNC | P24863 | 1/20 | 0.40 |
| ▸ | CDK8 | P49336 | 1/20 | 0.40 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALPL | P05186 | 1/20 | 0.40 |
| ▸ | ALPI | P09923 | 1/20 | 0.40 |
| ▸ | ALPG | P10696 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9101711 | 0.93 | PARP1 (0.42) | BRD4PARP1L3MBTL1CCNCCDK8 | |
| SCHEMBL9106967 | 0.91 | MEN1 (0.43) | PARP1L3MBTL1CCNCCDK8HASPIN | |
| SCHEMBL9104266 | 0.90 | CDK9 (0.47) | CCNT1CDK9BRD4MEN1KMT2A | |
| SCHEMBL9103993 | 0.90 | CCNT1 (0.42) | CCNT1CDK9BRD4MEN1KMT2A | |
| SCHEMBL9101391 | 0.90 | SCN9A (0.41) | CCNT1CDK9BRD4PARP1L3MBTL1 | |
| SCHEMBL9101704 | 0.90 | USP30 (0.41) | CCNT1CDK9BRD4PARP1L3MBTL1 | |
| SCHEMBL9895631 | 0.89 | BRD4 (0.42) | CCNT1CDK9BRD4IDO1PARP1 | |
| SCHEMBL9103135 | 0.89 | CCNT1 (0.49) | CCNT1CDK9MEN1KMT2A | |
| SCHEMBL9103325 | 0.89 | CCNT1 (0.44) | CCNT1CDK9BRD4MEN1KMT2A | |
| SCHEMBL9103928 | 0.88 | CCNT1 (0.45) | CCNT1CDK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8816085-B2 | Methylpyrrolopyridinecarboxamides | TAKEDA GMBH (DE) | 2014-08-26 | — | — | US | disclosed |
| US-20120142633-A1 | METHYLPYRROLOPYRIDINECARBOXAMIDES | NYCOMED GMBH (DE) | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142633-A1 | METHYLPYRROLOPYRIDINECARBOXAMIDES | PDE5A, PDE3A, PDE2A | CCNT1 1888/4885CDK9 1048/4885BRD4 465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.